{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:05:04Z","timestamp":1777881904627,"version":"3.51.4"},"publisher-location":"Cham","reference-count":71,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032231710","type":"print"},{"value":"9783032231727","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-23172-7_8","type":"book-chapter","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:56:39Z","timestamp":1777596999000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of Carbonic Anhydrase Inhibitors in Arthritis, Neuropathic Pain, Acute Mountain Sickness, and Cerebral Ischemia"],"prefix":"10.1007","author":[{"given":"Alessio","family":"Nocentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Pundeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1021\/acs.jmedchem.8b00420","volume":"61","author":"O Akgul","year":"2018","unstructured":"Akgul O, Di Cesare Mannelli L, Vullo D, Angeli A, Ghelardini C, Bartolucci G, Alfawaz Altamimi AS, Scozzafava A, Supuran CT, Carta F (2018) Discovery of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the management of rheumatoid arthritis. J Med Chem 61:4961\u20134977","journal-title":"J Med Chem"},{"key":"8_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113956","volume":"227","author":"\u00d6 Akg\u00fcl","year":"2022","unstructured":"Akg\u00fcl \u00d6, Lucarini E, Di Cesare Mannelli L, Ghelardini C, D\u2019Ambrosio K, Buonanno M, Monti SM, De Simone G, Angeli A, Supuran CT, Carta F (2022) Sultam based carbonic anhydrase VII inhibitors for the management of neuropathic pain. Eur J Med Chem 227:113956","journal-title":"Eur J Med Chem"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320:1360\u20131372","journal-title":"JAMA"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","volume":"154","author":"A Angeli","year":"2018","unstructured":"Angeli A, di Cesare Mannelli L, Lucarini E, Peat TS, Ghelardini C, Supuran CT (2018) Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects. Eur J Med Chem 154:210\u2013219","journal-title":"Eur J Med Chem"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejmech.2019.05.058","volume":"177","author":"A Angeli","year":"2019","unstructured":"Angeli A, Di Cesare Mannelli L, Ghelardini C, Peat TS, Bartolucci G, Menicatti M, Carta F, Supuran CT (2019) Benzenesulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects. Eur J Med Chem 177:188\u2013197","journal-title":"Eur J Med Chem"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/acs.jmedchem.2c01911","volume":"66","author":"A Angeli","year":"2023","unstructured":"Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, Ferrer Montiel A, Di Cesare Mannelli L, Ghelardini C, Supuran CT (2023) First-in-class dual hybrid carbonic anhydrase inhibitors and transient receptor potential vanilloid 1 agonists revert oxaliplatin-induced neuropathy. J Med Chem 66:1616\u20131633","journal-title":"J Med Chem"},{"key":"8_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115783","volume":"260","author":"A Angeli","year":"2023","unstructured":"Angeli A, Micheli L, Turnaturi R, Pasquinucci L, Parenti C, Alterio V, Di Fiore A, De Simone G, Monti SM, Carta F, Di Cesare Mannelli L, Ghelardini C, Supuran CT (2023) Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for \u03bc opioid receptor for safer and long-lasting analgesia. Eur J Med Chem 260:115783","journal-title":"Eur J Med Chem"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","volume":"148","author":"M Asiedu","year":"2010","unstructured":"Asiedu M, Ossipov MH, Kaila K, Price TJ (2010) Acetazolamide and midazolam act synergistically to inhibit neuropathic pain. Pain 148:302\u2013308","journal-title":"Pain"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpain.2014.01.001","volume":"15","author":"MN Asiedu","year":"2014","unstructured":"Asiedu MN, Mejia GL, H\u00fcbner CA, Kaila K, Price TJ (2014) Inhibition of carbonic anhydrase augments GABAA receptor-mediated analgesia via a spinal mechanism of action. J Pain 15:395\u2013406","journal-title":"J Pain"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nbd.2009.11.009","volume":"37","author":"LI Benowitz","year":"2010","unstructured":"Benowitz LI, Carmichael ST (2010) Promoting axonal rewiring to improve outcome after stroke. Neurobiol Dis 37:259\u2013266","journal-title":"Neurobiol Dis"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1021\/acs.jmedchem.9b00845","volume":"62","author":"E Berrino","year":"2019","unstructured":"Berrino E, Milazzo L, Micheli L, Vullo D, Angeli A, Bozdag M, Nocentini A, Menicatti M, Bartolucci G, Di Cesare Mannelli L, Ghelardini C, Supuran CT, Carta F (2019) Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis. J Med Chem 62:7233\u20137249","journal-title":"J Med Chem"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/14656566.2025.2474574","volume":"26","author":"A Bonardi","year":"2025","unstructured":"Bonardi A, Supuran CT (2025) Polypharmacology of carbonic anhydrase inhibitors and activators. Expert Opin Pharmacother 26:567\u2013580","journal-title":"Expert Opin Pharmacother"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"13143","DOI":"10.1021\/acs.jmedchem.2c00982","volume":"65","author":"A Bonardi","year":"2022","unstructured":"Bonardi A, Micheli L, Di Cesare Mannelli L, Ghelardini C, Gratteri P, Nocentini A, Supuran CT (2022) Development of hydrogen sulfide-releasing carbonic anhydrases IX- and XII-selective inhibitors with enhanced antihyperalgesic action in a rat model of arthritis. J Med Chem 65:13143\u201313157","journal-title":"J Med Chem"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","volume":"136","author":"D Bouhassira","year":"2008","unstructured":"Bouhassira D, Lant\u00e9ri-Minet M, Attal N, Laurent B, Touboul C (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380\u2013387","journal-title":"Pain"},{"issue":"S1","key":"8_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1055\/s-2007-1024597","volume":"13","author":"AR Bradwell","year":"1992","unstructured":"Bradwell AR, Wright AD, Winterborn M, Imray C (1992) Acetazolamide and high altitude diseases. Int J Sports Med 13(S1):S63\u2013S64","journal-title":"Int J Sports Med"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1021\/acs.jmedchem.9b01130","volume":"63","author":"S Bua","year":"2020","unstructured":"Bua S, Lucarini L, Micheli L, Menicatti M, Bartolucci G, Selleri S, Di Cesare Mannelli L, Ghelardini C, Masini E, Carta F, Gratteri P, Nocentini A, Supuran CT (2020) Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug\u2013carbonic anhydrase inhibitor hybrids for the management of rheumatoid arthritis. J Med Chem 63:2325\u20132342","journal-title":"J Med Chem"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3390\/ijms22095029","volume":"22","author":"I Bulli","year":"2021","unstructured":"Bulli I, Dettori I, Coppi E, Cherchi F, Venturini M, Di Cesare Mannelli L, Ghelardini C, Nocentini A, Supuran CT, Pugliese AM, Pedata F (2021) Role of carbonic anhydrase in cerebral ischemia and carbonic anhydrase inhibitors as putative protective agents. Int J Mol Sci 22:5029","journal-title":"Int J Mol Sci"},{"key":"8_CR18","first-page":"6656","volume":"9","author":"J Burtscher","year":"2016","unstructured":"Burtscher J, Gatterer H, Faulhaber M, Burtscher M (2016) Acetazolamide pre-treatment before ascending to high altitudes: sustained effect on systemic blood pressure during submaximal exercise. Int J Clin Exp Med 9:6656\u20136662","journal-title":"Int J Clin Exp Med"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","volume":"23","author":"F Carta","year":"2015","unstructured":"Carta F, Di Cesare Mannelli L, Pinard M, Ghelardini C, Scozzafava A, McKenna R, Supuran CT (2015) A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem 23:1828\u20131840","journal-title":"Bioorg Med Chem"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2474-11-279","volume":"11","author":"X Chang","year":"2010","unstructured":"Chang X, Han J, Zhao Y, Wang J, Li X (2010) Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskelet Disord 11:279","journal-title":"BMC Musculoskelet Disord"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1152\/japplphysiol.00589.2024","volume":"137","author":"JC Chang","year":"2024","unstructured":"Chang JC, Thompson BP, Doherty CJ, Mann LM, Berdeklis AN, Foster GE, Tupling AR, Swenson ER, Dominelli PB (2024) Effects of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. J Appl Physiol (1985) 137:1566\u20131579","journal-title":"J Appl Physiol (1985)"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pneurobio.2013.12.007","volume":"115","author":"F Chen","year":"2014","unstructured":"Chen F, Qi Z, Luo Y, Hinchliffe T, Ding G, Xia Y, Ji X (2014) Non-pharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol 115:246\u2013269","journal-title":"Prog Neurobiol"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","volume":"125","author":"K D\u2019Ambrosio","year":"2025","unstructured":"D\u2019Ambrosio K, Di Fiore A, Alterio V, Langella E, Monti SM, Supuran CT, De Simone G (2025) Multiple binding modes of inhibitors to human carbonic anhydrases: an update on the design of isoform-specific modulators of activity. Chem Rev 125:150\u2013222","journal-title":"Chem Rev"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.2174\/0929867322666150716113501","volume":"22","author":"C De Monte","year":"2015","unstructured":"De Monte C, Carradori S, Gentili A, Mollica A, Trisciuoglio D, Supuran CT (2015) Dual cyclooxygenase and carbonic anhydrase inhibition by nonsteroidal anti-inflammatory drugs for the treatment of cancer. Curr Med Chem 22:2812\u20132818","journal-title":"Curr Med Chem"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/14756366.2021.1907575","volume":"36","author":"I Dettori","year":"2021","unstructured":"Dettori I, Fusco I, Bulli I, Gaviano L, Coppi E, Cherchi F, Venturini M, Di Cesare Mannelli L, Ghelardini C, Nocentini A, Supuran CT, Pugliese AM, Pedata F (2021) Protective effects of carbonic anhydrase inhibition in brain ischemia in vitro and in vivo models. J Enzyme Inhib Med Chem 36:964\u2013976","journal-title":"J Enzyme Inhib Med Chem"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3109\/14756366.2015.1113407","volume":"31","author":"L Di Cesare Mannelli","year":"2016","unstructured":"Di Cesare Mannelli L, Micheli L, Carta F, Cozzi A, Ghelardini C, Supuran CT (2016) Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors. J Enzyme Inhib Med Chem 31:894\u2013899","journal-title":"J Enzyme Inhib Med Chem"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/138161208783877938","volume":"14","author":"JM Dogn\u00e9","year":"2008","unstructured":"Dogn\u00e9 JM, Thiry A, Supuran CT (2008) Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs. Curr Pharm Des 14:679\u2013684","journal-title":"Curr Pharm Des"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J, Baron R, Gourlay GK, Haanp\u00e4\u00e4 ML et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3\u2013S14","journal-title":"Mayo Clin Proc"},{"key":"8_CR29","first-page":"99","volume":"3","author":"M Farr","year":"1985","unstructured":"Farr M, Garvey K, Bold AM, Smith D, Brown N (1985) Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. Clin Exp Rheumatol 3:99\u2013104","journal-title":"Clin Exp Rheumatol"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"EVIDoa2100006","DOI":"10.1056\/EVIDoa2100006","volume":"1","author":"M Furian","year":"2022","unstructured":"Furian M, Mademilov M, Buergin A, Scheiwiller PM, Mayer L, Schneider S, Emilov B, Lichtblau M, Bitos K, Muralt L, Groth A, Reiser AE, Sevik A, Sheraliev U, Muratbekova A, Tabyshova A, Abdraeva A, Buenzli S, Sooronbaev TM, Ulrich S, Bloch KE (2022) Acetazolamide to prevent adverse altitude effects in COPD and healthy adults. NEJM Evid 1:EVIDoa2100006","journal-title":"NEJM Evid"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1534","volume":"13","author":"B-B Gao","year":"2007","unstructured":"Gao B-B, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP, Feener EP (2007) Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med 13:181\u2013188","journal-title":"Nat Med"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/jcbfm.2013.102","volume":"33","author":"CL Gibson","year":"2013","unstructured":"Gibson CL (2013) Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab 33:1355\u20131361","journal-title":"J Cereb Blood Flow Metab"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.tips.2025.07.002","volume":"46","author":"S Giovannuzzi","year":"2025","unstructured":"Giovannuzzi S, Supuran CT (2025) Human carbonic anhydrase modulators: the past, present, and future. Trends Pharmacol Sci 46:836\u2013847","journal-title":"Trends Pharmacol Sci"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-116-6-461","volume":"116","author":"CK Grissom","year":"1992","unstructured":"Grissom CK, Roach RC, Sarnquist FH, Hackett PH (1992) Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 116:461\u2013465","journal-title":"Ann Intern Med"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12975-011-0106-0","volume":"3","author":"F Guo","year":"2012","unstructured":"Guo F, Hua Y, Wang J, Keep RF, Xi G (2012) Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage. Transl Stroke Res 3:130\u2013137","journal-title":"Transl Stroke Res"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuint.2005.08.007","volume":"48","author":"P Halmi","year":"2006","unstructured":"Halmi P, Parkkila S, Honkaniemi J (2006) Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 48:24\u201330","journal-title":"Neurochem Int"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20151739","volume":"213","author":"EK Henry","year":"2016","unstructured":"Henry EK, Sy CB, Inclan-Rico JM, Espinosa V, Ghanny SS, Dwyer DF, Soteropoulos P, Rivera A, Siracusa MC (2016) Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med 213:1663\u20131673","journal-title":"J Exp Med"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/jcbfm.1991.109","volume":"11","author":"K Katsura","year":"1991","unstructured":"Katsura K, Ekholm A, Asplund B, Siesj\u00f6 BK (1991) Extracellular pH in the brain during ischemia: relationship to the severity of lactic acidosis. J Cereb Blood Flow Metab 11:597\u2013599","journal-title":"J Cereb Blood Flow Metab"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/57.1.18","volume":"57","author":"I Klatzo","year":"1985","unstructured":"Klatzo I (1985) Brain oedema following brain ischaemia and the influence of therapy. Br J Anaesth 57:18\u201322","journal-title":"Br J Anaesth"},{"key":"8_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/354594","volume":"2012","author":"C Liu","year":"2012","unstructured":"Liu C, Wei Y, Wang J, Chang J, Li X, Zhang Y (2012) Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure. Clin Dev Immunol 2012:354594","journal-title":"Clin Dev Immunol"},{"issue":"suppl 4","key":"8_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","volume":"31","author":"F Margheri","year":"2016","unstructured":"Margheri F, Ceruso M, Carta F, Laurenzana A, Maggi L, Lazzeri S, Simonini G, Annunziato F, Del Rosso M, Supuran CT, Cimaz R (2016) Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium. J Enzyme Inhib Med Chem 31(suppl 4):60\u201363","journal-title":"J Enzyme Inhib Med Chem"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/13543776.2013.794788","volume":"23","author":"E Masini","year":"2013","unstructured":"Masini E, Carta F, Scozzafava A, Supuran CT (2013) Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 23:705\u2013716","journal-title":"Expert Opin Ther Pat"},{"key":"8_CR43","first-page":"43","volume":"4","author":"AA McDonald","year":"2006","unstructured":"McDonald AA, Portenoy RK (2006) How to use antidepressants and anticonvulsants as adjuvant analgesics in the treatment of neuropathic cancer pain. J Support Oncol 4:43\u201352","journal-title":"J Support Oncol"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955\u20132007. Arthritis Rheum 62:1576\u20131582","journal-title":"Arthritis Rheum"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumors as a therapeutic strategy. Nat Rev Drug Discov 10:767\u2013777","journal-title":"Nat Rev Drug Discov"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","volume":"28","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Supuran CT (2018) Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018). Expert Opin Ther Pat 28:729\u2013740","journal-title":"Expert Opin Ther Pat"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1021\/acs.jmedchem.9b02135","volume":"63","author":"A Nocentini","year":"2020","unstructured":"Nocentini A, Alterio V, Bua S, Micheli L, Esposito D, Buonanno M, Bartolucci G, Osman SM, ALothman ZA, Cirilli R, Pierini M, Monti SM, Di Cesare Mannelli L, Gratteri P, Ghelardini C, De Simone G, Supuran CT (2020) Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy. J Med Chem 63:5185\u20135200","journal-title":"J Med Chem"},{"issue":"1","key":"8_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","volume":"36","author":"A Nocentini","year":"2021","unstructured":"Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT (2021) Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 36(1):561\u2013580","journal-title":"J Enzyme Inhib Med Chem"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antibiotics12010142","volume":"12","author":"A Nocentini","year":"2023","unstructured":"Nocentini A, Capasso C, Supuran CT (2023) Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now? Antibiotics (Basel) 12:142","journal-title":"Antibiotics (Basel)"},{"key":"8_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/1043-6618(91)90042-V","volume":"24","author":"JC Nolan","year":"1991","unstructured":"Nolan JC, Gathright CE, Radvany CH, Barrett RJ, Sancilio LF (1991) Carbonic anhydrase inhibitors are antiarthritic in the rat. Pharmacol Res 24:377\u2013383","journal-title":"Pharmacol Res"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/eurheartj\/ehs140","volume":"34","author":"G Parati","year":"2013","unstructured":"Parati G, Revera M, Giuliano A, Faini A, Bilo G, Gregorini F, Lisi E, Salerno S, Lombardi C, Ramos Becerra CG, Mancia G, Salvi P (2013) Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J 34:759\u2013766","journal-title":"Eur Heart J"},{"key":"8_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2362.1997.1260668.x","volume":"27","author":"AK Parkkila","year":"1997","unstructured":"Parkkila AK, Parkkila S, Reunanen M, Niemel\u00e4 O, Tuisku S, Rautakorpi I, Rajaniemi H (1997) Carbonic anhydrase II in the cerebrospinal fluid: its value as a disease marker. Eur J Clin Investig 27:392\u2013397","journal-title":"Eur J Clin Investig"},{"key":"8_CR53","doi-asserted-by":"crossref","unstructured":"Porcelli MJ, Gugelchuk GM (1995) A trek to the top: a review of acute mountain sickness. J Am Osteopath Assoc 95(12):718\u2013720","DOI":"10.7556\/jaoa.1995.95.12.718"},{"key":"8_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.hrtlng.2003.08.002","volume":"32","author":"GW Rodway","year":"2003","unstructured":"Rodway GW, Hoffman LA, Sanders MH (2003) High-altitude-related disorders\u2014Part I: Pathophysiology, differential diagnosis, and treatment. Heart Lung 32:353\u2013359","journal-title":"Heart Lung"},{"key":"8_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/cs0740225","volume":"74","author":"PN Sambrook","year":"1988","unstructured":"Sambrook PN, Reeve J (1988) Bone disease in rheumatoid arthritis. Clin Sci 74:225\u2013230","journal-title":"Clin Sci"},{"key":"8_CR56","first-page":"349","volume-title":"Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications","author":"A Scozzafava","year":"2013","unstructured":"Scozzafava A, Supuran CT (2013) Glaucoma and the applications of carbonic anhydrase inhibitors. In: Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications. Springer, Dordrecht, pp 349\u2013359"},{"key":"8_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/jcbfm.1981.18","volume":"1","author":"BK Siesj\u00f6","year":"1981","unstructured":"Siesj\u00f6 BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155\u2013185","journal-title":"J Cereb Blood Flow Metab"},{"key":"8_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001","journal-title":"Nat Rev Dis Primers"},{"key":"8_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/papr.12054","volume":"14","author":"SJ Snedecor","year":"2014","unstructured":"Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Mehta S, Botteman M (2014) Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract 14:167\u2013184","journal-title":"Pain Pract"},{"key":"8_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/aps.2013.149","volume":"35","author":"YJ Sun","year":"2014","unstructured":"Sun YJ, Chen Y, Pang C, Wu N, Li J (2014) Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice. Acta Pharmacol Sin 35:41\u201347","journal-title":"Acta Pharmacol Sin"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168\u2013181","journal-title":"Nat Rev Drug Discov"},{"key":"8_CR62","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/14737175.2015.1066675","volume":"15","author":"CT Supuran","year":"2015","unstructured":"Supuran CT (2015) Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 15:851\u2013856","journal-title":"Expert Rev Neurother"},{"key":"8_CR63","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.124.001125","volume":"77","author":"CT Supuran","year":"2025","unstructured":"Supuran CT (2025) Multi- and polypharmacology of carbonic anhydrase inhibitors. Pharmacol Rev 77:100004","journal-title":"Pharmacol Rev"},{"key":"8_CR64","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.chest.2022.01.024","volume":"161","author":"ER Swenson","year":"2022","unstructured":"Swenson ER (2022) Chronic mountain sickness evolving over time: new data from on high. Chest 161:1136\u20131137","journal-title":"Chest"},{"key":"8_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/rccm.200608-1199OC","volume":"175","author":"LJ Teppema","year":"2007","unstructured":"Teppema LJ, Balanos GM, Dahan A, Berkenbosch A, DeGoede J, Olievier CN, Robbins PA (2007) Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med 175:277\u2013281","journal-title":"Am J Respir Crit Care Med"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2174\/156802607780636726","volume":"7","author":"A Thiry","year":"2007","unstructured":"Thiry A, Dogn\u00e9 JM, Masereel B, Supuran CT (2007) Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 7:855\u2013864","journal-title":"Curr Top Med Chem"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"JR Vane","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97\u2013120","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.mayocp.2016.01.017","volume":"91","author":"JC Watson","year":"2016","unstructured":"Watson JC, Sandroni P (2016) Central neuropathic pain syndromes. Mayo Clin Proc 91:372\u2013385","journal-title":"Mayo Clin Proc"},{"key":"8_CR69","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"A Weber","year":"2004","unstructured":"Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47:550\u2013557","journal-title":"J Med Chem"},{"key":"8_CR70","first-page":"S31","volume":"20","author":"A Whelton","year":"2002","unstructured":"Whelton A (2002) COX-2-specific inhibitors and the kidney: effect on hypertension and oedema. J Hypertens Suppl 20:S31\u2013S35","journal-title":"J Hypertens Suppl"},{"key":"8_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000087655","volume":"14","author":"J Wieseler-Frank","year":"2005","unstructured":"Wieseler-Frank J, Maier SF, Watkins LR (2005) Central proinflammatory cytokines and pain enhancement. Neurosignals 14:166\u2013174","journal-title":"Neurosignals"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-23172-7_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:56:40Z","timestamp":1777597000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-23172-7_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032231710","9783032231727"],"references-count":71,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-23172-7_8","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}